Infection News

These reports include research on the impact of the microbiome on obesity, asthma and COVID-19.

In this exclusive video, Miguel Regueiro, MD, from Cleveland Clinic, discusses some of the hot topics from Advances in Inflammatory Bowel Disease 2020, including the rollout of the COVID-19 vaccine.

Asymptomatic Clostridioides difficile colonization is significantly associated with previous hospitalization, gastric acid suppression, tube feeding and corticosteroid use, according to a systematic review and meta-analysis.

In a minimal monitoring – or “Minmon” – study, patients given a full regimen for hepatitis C virus and then remotely monitored achieved 95% sustained virologic response, according to a presenter at The Liver Meeting Digital Experience.

Children with COVID-19 and multisystem inflammatory syndrome had varied outcomes and liver injuries but all should keep long-term liver monitoring to ensure return to normal levels, per a researcher at The Liver Meeting Digital Experience.

In a year of unprecedented health and social challenges, the American College of Gastroenterology president saw the good that will come from professional medical societies leading the change.

In this exclusive video from ACG Virtual Annual Meeting, Gabriela Kuftinec, MD MPH, from the department of medicine, division of gastroenterology, University of Miami Leonard M. Miller School of Medicine, discusses the development of a stool color tool that may aid in the diagnosis of gastrointestinal bleeding.

During this year’s ACG 2020 Virtual meeting, Healio will host its annual Disruptive Innovators Award ceremony on Monday, October 26.

The investigational oral microbiome drug CP101 helped prevent recurrence of Clostridioides difficile infection across a broad population of patients, according to research presented at UEG Week Virtual.

In this exclusive video, Freddy Caldera, DO, MS, from the division of gastroenterology and hepatology at the University of Wisconsin School of Medicine and Public Health, discusses his paper on reducing the risk for vaccine preventable disease during the COVID-19 pandemic.